BBG-26478-09542
1 vaccination
1 coded response
16 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 054 / VT
- Registered
- 2021-06-02
- Relationship
- Self
- Race
- Other
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-02
Registered in v-safe
-
2021-06-02
Dose 1 — Janssen/Johnson & Johnson
- 2021-06-02
-
2021-06-03
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-06-04
- 2021-06-05
- 2021-06-06
- 2021-06-07
- 2021-06-08
- 2021-06-09
- 2021-06-16
- 2021-06-23
- 2021-06-30
- 2021-07-09
- 2021-07-16
- 2021-09-01
- 2021-12-03
-
2022-06-02
Survey response — 12 months, dose 1MedDRA: Anosmia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Loss of smellMedDRA releases: 2024-11 · check-in free text available
-
2022-06-02
Report sent to call center — 12 months, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-06-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-02 | Janssen/Johnson & Johnson |
Call center
1 call center case
1 unsuccessful
Free text
Release 11 — 12 months, dose 1
Symptoms: Loss of smell
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anosmia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release